Neonates, especially those born preterm or with certain congenital conditions, are at increased risk for developing blood clots. Conditions such as neonatal sepsis, congenital heart disease, and the use of central venous catheters can elevate this risk. LMWH is often preferred over unfractionated heparin in neonates due to its ease of administration and monitoring, as well as its safety profile.
